• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ORTHO-CLINICAL DIAGNOSTICS VITROS CHEMISTRY PRODUCTS BUBC SLIDES; IN VITRO DIAGNOSTICS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ORTHO-CLINICAL DIAGNOSTICS VITROS CHEMISTRY PRODUCTS BUBC SLIDES; IN VITRO DIAGNOSTICS Back to Search Results
Catalog Number 1612365
Device Problem High Test Results (2457)
Patient Problem Test Result (2695)
Event Date 12/18/2019
Event Type  malfunction  
Manufacturer Narrative
The investigation determined that higher than expected vitros calcium (ca) results were attained from a non-vitros biorad quality control (qc) fluid using vitros chemistry products ca slides lot 0332-0585-2088 in combination with a vitros 350 chemistry system.Lower than expected unconjugated bilirubin results were attained from a vitros performance verifier (pv) fluid processed using vitros chemistry products bubc slides lot 0244-0426-2893 on a vitros 350 chemistry system.The assignable cause of the higher and lower than expected results is unknown.Multiple service actions were performed on the vitros 350 chemistry system including cleaning the reflectometer assembly, performing adjustments on the incubator/dispense path, incubator cm depth, and read sync; processing correction factors and running the static test.Additionally, calibrations of the vitros ca and bubc assays were performed after the service actions.Therefore, it is unknown if the cause is analyzer or calibration related.The field engineer (fe) did not process pre and post service precision runs, therefore, it is unknown how the analyzer was running prior to the service actions.Therefore, the analyzer cannot be fully confirmed or ruled out as a potential contributor to this event.Historical vitros ca qc showed unacceptable precision.Following the service actions and calibrations performed, the qc was as expected indicating that a vitros ca reagent lot performance issue is not a likely contributor to the event.Historical qc data was not available for vitros bu, however, the customer indicated that the direct bilirubin values were as expected since the service actions and calibrations were performed by the fe.Therefore, a vitros bubc reagent lot performance issue is not a likely contributor to the event.
 
Event Description
A customer reported higher than expected vitros calcium (ca) results obtained from a non-vitros biorad quality control (qc) fluid processed using vitros chemistry products ca slides in combination with a vitros 350 chemistry system.The customer also reported lower than expected unconjugated bilirubin results obtained from a vitros performance verifier (pv) fluid processed using vitros chemistry products bubc slides on a vitros 350 chemistry system.Vitros pvii lot j6978 bu results of 6.6, 6.7, 6.7 and 6.7 mg/dl versus an expected result of 10.0 mg/dl.Biorad lot 45830 l1 ca results of 11.11 and 11.0 mg/dl versus an expected result of 6.16 mg/dl.Biased results of the magnitude and direction observed may lead to inappropriate physician action if they were to occur undetected on patient samples.Both the lower and higher than expected results occurred on qc fluids only, and the customer stopped processing patients for the affected assays after obtaining the lower and higher than expected qc results.There was no allegation of patient harm as a result of this event.This report is number 3 of 6 mdr¿s for this event.Six (6) 3500a forms are being submitted for this event as 6 devices were involved.This report corresponds to ortho clinical diagnostics inc.Complaint numbers (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VITROS CHEMISTRY PRODUCTS BUBC SLIDES
Type of Device
IN VITRO DIAGNOSTICS
Manufacturer (Section D)
ORTHO-CLINICAL DIAGNOSTICS
100 indigo creek drive
rochester NY 14626
Manufacturer (Section G)
ORTHO-CLINICAL DIAGNOSTICS
513 technology blvd.
rochester NY 14652
Manufacturer Contact
james a stevens
100 indigo creek drive
rochester, NY 14626
5854533000
MDR Report Key9592990
MDR Text Key214633242
Report Number1319809-2020-00003
Device Sequence Number1
Product Code CIG
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Other
Type of Report Initial
Report Date 01/15/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/15/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/01/2021
Device Catalogue Number1612365
Device Lot Number0244-0426-2893
Was Device Available for Evaluation? Yes
Date Manufacturer Received12/18/2019
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured09/18/2019
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
-
-